Epygenix-Homepage-Hero-Neurons revised 2.png

A Better
Tomorrow

For People Living with Rare Genetic Epilepsies

Powered by a highly predictive genetic screening platform, Epygenix is a clinical stage biopharmaceutical company focused on developing treatments for rare and intractable genetic epilepsies.

Get informed when we launch our new website:

Thanks for submitting. We will let you know when the new website goes live!

Our New Website
is Coming Soon

CONTACT US

140 E. Ridgewood Ave. Suite 415, South Tower, Paramus, NJ 07652